MktsMarkets

PLUS THERAPEUTICS, Inc.
NASDAQ: PSTVKey statistics
PSTV News
Stories mentioning PSTV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,028 | 1,367 | 1,397 | 1,390 | 1,059 | 1,412 | 1,456 | 1,279 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 2,865 | 2,941 | 2,436 | 1,246 | 1,756 | 2,186 | 2,858 | 2,773 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 8,147 | 7,109 | 5,879 | 2,928 | 4,595 | 5,312 | 5,255 | 4,976 |
| Operating Income (Loss) | (7,119) | (5,742) | (4,482) | (1,538) | (3,536) | (3,900) | (3,799) | (3,697) |
| Interest Income | 190.00 | 29.00 | 59.00 | 27.00 | 1.00 | 54.00 | 80.00 | 67.00 |
| Interest Expense | 27.00 | |||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (6,946) | (5,713) | (4,423) | 5,151 | (17,401) | (3,903) | (2,874) | (2,940) |
| Earnings Per Share (Basic) | (1.05) | (0.07) | (0.04) | 0.02 | (29.86) | (0.59) | (0.37) | (0.45) |
| Earnings Per Share (Diluted) | (1.05) | (0.07) | (0.04) | (0.01) | (29.86) | (0.51) | (0.37) | (0.71) |
| Weighted Average Shares Outstanding (Basic) | 6,646 | 77,805 | 107,429 | 48,389 | 583.00 | 6,640 | 7,856 | 6,501 |
| Weighted Average Shares Outstanding (Diluted) | 6,646 | 77,805 | 107,429 | 209,155 | 583.00 | 7,701 | 7,856 | 10,743 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PSTV
PLUS THERAPEUTICS, Inc. (NASDAQ: PSTV) is a stock listed on the Nasdaq Stock Market under the ticker symbol PSTV. It last traded at $0.7100 (Nov 17, 2026, 7:00 PM ET), up 12.7% on the day. That gives PLUS THERAPEUTICS a market capitalisation of $26.6M.
Over the past 52 weeks PSTV has traded between $0.4300 and $18.88.
Revenue for the quarter ended Mar 31, 2026 was $1.0M; a net loss of $6.9M. Revenue was down 2.9% from $1.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.0M | -$6.9M | -675.7% |
| Dec 31, 2025 | $1.4M | -$5.7M | -417.9% |
| Sep 30, 2025 | $1.4M | -$4.4M | -316.6% |
| Jun 30, 2025 | $1.4M | $5.2M | 370.6% |
From PLUS THERAPEUTICS’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…